WB: Chemoimmunotherapy Not Linked With Overall Benefit Vs. Immunotherapy Alone
Chemoimmunotherapy was linked with no survival advantage versus immunotherapy alone in advanced non-small cell lung cancer during the entire follow-up period. In patients with advance...